Breast Cancer CME
Our breast cancer CME opportunities include online activities and regional live meetings. Experts in the field present current information and novel treatment approaches discussed in the latest studies and breast cancer conference meetings.
Designed for physicians, nurse practitioners, and physician assistants, this program provides education about molecular testing and HER-2 positivity in breast cancer. The multifaceted self-study module provides expert guidance regarding personalized treatment selection and sequencing for patients with HER-2 positive breast cancer. It includes neoadjuvant and adjuvant therapies, as well as strategies for improving patient engagement via education and shared decision-making. You will be able to respond to questions and compare your answers to those of your peers in this interactive and fast-paced activity.
This activity stresses appropriate use of treatment guidelines, incorporating targeted treatment paradigms, and engaging patients in the decision-making process regarding therapeutic options. These elements are essential to the improvement of outcomes in patients with HER2-positive breast cancer.